Chronic oral administration of arginine induces GH gene expression and insulin resistance

Life Sciences

Volumn 79, Issue 15, 2006, Pages 1444-1449

  de Castro Barbosa, Thais ^a   Lourenço Poyares, Leonice ^a   Fabres Machado, Ubiratan ^a   Nunes, Maria Tereza ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Arginine; GH mRNA expression; Insulin plasma concentration; Insulin resistance; ITT; kitt

Indexed keywords

ARGININE; GLUCOSE; GROWTH HORMONE; INSULIN; MESSENGER RNA; NITRIC OXIDE; WATER;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BLOOD GLUCOSE MONITORING; CHRONIC TOXICITY; CONTROLLED STUDY; FLUID INTAKE; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART RATE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; MALE; NERVE CELL; NONHUMAN; NORTHERN BLOTTING; RAT; REGULATORY MECHANISM;

ADMINISTRATION, ORAL; ANIMALS; ARGININE; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; DRINKING; EATING; GENE EXPRESSION; GROWTH HORMONE; HEART RATE; INSULIN; INSULIN RESISTANCE; MALE; RATS; RATS, WISTAR; RNA, MESSENGER;

ANIMALIA;

EID: 33747460393     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.04.004     Document Type: Article

References (46)

1. Adrião M., Chrisman C.J.S., Bielasvsky M., Olinto S.C., Shiraishi E.M., and Nunes M.T. Arginine increases growth hormone gene expression in rat pituitary and GH3 cells. Neuroendocrinology 79 (2004) 26-33
2. Alba-Roth J., Müller O.A., Schopohl J., and von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. The Journal of Clinical Endocrinology and Metabolism 67 (1988) 1186-1189
3. Appleton J. Arginine: clinical potential of semi-essential amino. Alternative Medicine Review 7 (2002) 512-522
4. Blum A., Hathaway L., Mincemoyer R., Schenke W.H., Kirby M., Csako G., Waclawiw M.A., Panza J.A., and Cannon R.O. Oral l-arginine in patients with coronary artery disease on medical management. Circulation 101 18 (2000) 2160-2164
5. Blum A., Cannon R.O., Costello R., Cannon R.O., and Csako G. Endocrine and lipid effects of oral l-arginine treatment in healthy postmenopausal women. The Journal of Laboratory and Clinical Medicine 135 (2000) 231-237
6. Bode-Böger S.M., Böger R.H., Galland A., Tsikas D., and Frolich J.C. l-Arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. British Journal of Clinical Pharmacology 46 5 (1998) 489-497
7. Bolea S., Pertusa J.A., Martín F., Sanches-Andres J.V., and Soria B. Regulation of pancreatic beta-cell electrical activity and insulin release by physiological amino acid concentrations. European Journal of Applied Physiology 433 (1997) 699-704
8. Bonora E., Moghetti P., Zancanaro C., Cigolini M., Querena M., Cacciatoni V., Corgnati A., and Muggeo M. Estimates of in vivo insulin action in man: comparison of insulin tolerance test with euglycemic and hyperglycemic glucose clamp studies. The Journal of Clinical Endocrinology and Metabolism 68 (1989) 374-378
9. Ceccatelli S. Expression and plasticity of NO synthase in the neuroendocrinology system. Brain Research Bulletin 44 (1997) 533-538
10. Chomczynski P., and Sacchi N. Single-step method RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 (1987) 156-159
11. Chowdhary S., and Townend J.N. Role of nitric oxide in the regulation of cardiovascular autonomic control. Clinical Science (London) 97 (1999) 5-17
12. Chowdhary S., Vaile J.C., Fletcher J., Ross H.F., Coote J.H., and Townend J.N. Nitric oxide and cardiac autonomic control in human. Hypertension 36 (2000) 264-269
13. Chowdhary S., Nuttall S.I., Coote J.H., and Townend J.N. l-Arginine cardiac vagal control in healthy human subjects. Hypertension 39 (2002) 51-56
14. Chung H.O., Kato T., Tomizawa K., and Kato Y. Molecular coning of Pit-1 cDNA porcine anterior pituitary and its involvement in pituitary stimulation by growth hormone-releasing factor. Experimental and Clinical Endocrinology & Diabetes 106 (1998) 203-210
15. Clarkson P., Adams M.R., Powe A.J., Donald A.E., McCredie R., Robinson J., McCarthy S.N., Keech A., Celermajer D.S., and Deanfield J.E. Oral l-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. The Journal of Clinical Investigation 97 (1996) 1989-1994
16. Collier S.R., Casey D.P., and Kanaley J.A. Growth hormone responses to varying doses of oral arginine. Growth Hormone & IGF Research 15 (2005) 136-139
17. Cronin M.T., Summers S.T., Sortino M.A., and Hewlett E.L. Protein kinase C enhances growth hormone releasing factor-stimulated cyclic AMP levels in anterior pituitary. Actions of somatostatin and pertussis toxin. The Journal of Biological Chemistry 261 (1986) 13932-13935
18. French M.B., Moor B.C., Lussier B.T., and Kraicer J. Protein kinase C is not essential for growth hormone (GH)-releasing factor induced GH release from rat somatotrophs. Endocrinology 124 (1989) 2235-2244
19. French M.B., Lussier B.T., Moor B.C., and Kraicer J. Effect of growth hormone-releasing factor on phosphoinositide hydrolysis in somatotrophs. Molecular and Cellular Endocrinology 72 (1990) 221-226
20. Furuya D.T., Binsack R., and Machado U.F. Low ethanol consumption increases insulin sensitivity in Wistar rats. Brazilian Journal of Medical and Biological Research 36 1 (2003) 125-130
21. Gannon M.C., Nuttall J.A., and Nuttall F. Oral arginine does not stimulate an increase in insulin concentration but delays glucose disposal. American Journal of Clinical Nutrition 76 5 (2002) 1016-1022
22. Ghigo E., Bellone J., Mazza E., Imperiale E., Procopio M., Valente F., Lala R., De Sanctis C., and Camanni F. Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine. Clinical Endocrinology 32 (1990) 763-767
23. Ghigo E., Ceda G.P., Valcavi R., Goffi S., Zini M., Mucci M., Valeni G., Cocchi D., Muller E.E., and Camanni E. Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjects. Journal of Endocrinological Investigation 17 (1994) 113-117
24. Gokce N. l-Arginine and hypertension. Journal of Nutrition 134 (2004) 2807S-2811S
25. Gouvea S.A., Moyses M.R., Bissoli N.S., et al. Oral administration of l-arginine decreases blood pressure and increases renal excretion of sodium and water in renovascular hypertensive rats. Brazilian Journal of Medical and Biological Research 36 7 (2003) 943-949
26. Isidori A., Monaco A., and Cappa M. A study of growth hormone release in man after oral administration of amino acids. Current Medical Research and Opinion 7 (1981) 475-481
27. Kawano T., Nomura M., Nisikado A., Nakaya Y., and Ito S. Supplementation of l-arginine improves hypertension but not insulin resistance in diabetic rats. Life Sciences 73 (2003) 3017-3026
28. Kelijman M., and Frohman L.A. The role of the cholinergic pathway in growth hormone feedback. The Journal of Clinical Endocrinology and Metabolism 72 (1991) 1081-1087
29. Krege J.H., Hodgin J.B., Hagaman J.R., and Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 25 (1995) 1111-1115
30. Lin C., Lin S.C., Chang C.P., and Rosenfeld M.G. Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth. Nature 360 (1992) 765-768
31. 2+ concentration and growth hormone (GH) release from purified rat somatotrophs. III. Mechanism of action of GH-releasing factor and somatostatin. Endocrinology 128 (1991) 592-603
32. Mehta S., Steward D.J., and Levi R.D. The hypotensive effect of l-arginine is associated with increased expired nitric oxide in humans. Chest 109 6 (1996) 1550-1555
33. Merimee T.J., Lillicrap D.A., and Rabinowitz D. Effect of arginine on serum levels of human growth hormone. Lancet 2 (1965) 668-670
34. Miles P.D., Li S., Hart M., Romeo O., Cheng J., Cohen A., Raafat K., Moossa A.R., and Olefsky J.M. Mechanisms of insulin resistance in experimental hyperinsulinemic dogs. Journal of Clinical Investigation 101 (1998) 202-211
35. Nelson R.J., Kriegsfeld L.J., Dawson V.L., and Dawson T.M. Effects of nitric oxide on neuroendocrine function and behavior. Frontiers in Neuroendocrinology 18 (1997) 463-491
36. Ohata Y., Maruyama Y., Katoh K., and Sasaki Y. Growth hormone release induced by an amino acid mixture from primary cultured anterior pituitary cells of goats. Domestic Animal Endocrinology 14 (1997) 99-107
37. Popov D., Costache G., Georgeseu A., and Echane M. Beneficial effects of l-arginine supplementation in experimental hyperlipemia-hyperglycemia in hamsters. Cell & Tissue Research 308 (2002) 109-120
38. Sambrook J., Fritschi E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual vol. 1-3 (1989), Cold Spring Harbor Laboratory Press, Ney York
39. Thams P., and Capito K. l-Arginine stimulation of glucose-induced insulin secretion through membrane depolarization and independent of nitric oxide. European Journal of Endocrinology 140 (1999) 87-93
40. Tong B.C., and Barbul A. Cellular and physiological effects of arginine. Mini Reviews in Medicinal Chemistry 4 (2004) 823-832
41. Tripathy D., Eriksson K.F., Orho-Melander M., Fredriksson J., Ahlqvist G., and Groop L. Parallel insulin resistance and beta cell decompensation in type 2 diabetes. Diabetologia 47 (2004) 782-793
42. Villalobos C., Núnez L., and Garcia-Sancho J. Mechanisms for stimulation of rat anterior pituitary cells by arginine and other amino acids. Journal of Physiology (London) 502 (1997) 421-431
43. Windmueller H.G., and Spaeth A.E. Metabolism of absorbed aspartate, asparagines, and arginine by rat small intestine in vivo. Archives of Biochemistry and Biophysics 175 2 (1976) 670-676
44. Wu G., and Meininger C.J. Arginine nutrition and cardiovascular function. The Journal of Nutrition 130 (2000) 2626-2629
45. Wu G., and Morris S.M.J. Arginine metabolism: nitric oxide and beyond. Biochemical Journal 336 (1998) 1-17
46. Zhande R., Mitchell J.J., Wu J., and Sun X.J. Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1. Molecular and Cellular Biology 22 (2002) 1016-1026